The firm's quarterly earnings of 13 cents per share came in line with analyst estimates, while revenue came in at $3.66 billion, missing expectations. The company's customer base rose 17% ...
In mid-July, the stock for the cancer drug developer MEI Pharma skyrocketed. It wasn’t because the small company, first listed on the Nasdaq in 2003, had discovered a blockbuster cancer cure. Rather, ...
“What’s your sign?” That might be one of the cheesiest pickup lines ever. But if anyone asks traders on Wall Street that question on Friday, their answer should be Gemini, the Zodiac sign represented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback